BioSpace News Archive

Business

pSivida Corp. Announces First Quarter Fiscal Year 2018 Financial Results Release Date and Conference Call Information

Management will host a conference call to review the results at 8:30 a.m. ET on the same day.

October 18, 2017

·

2 min read

Policy

Photocure ASA: FDA Grants Priority Review for Cysview Supplemental New Drug Application (sNDA)

With the FDA granting a priority review, a decision is expected in the first half of 2018.

October 18, 2017

·

4 min read

Business

Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer

Dr. Baker will be an integral part of the executive team at Relievant, guiding technology development, clinical research strategy, and commercial initiatives.

October 18, 2017

·

3 min read

Business

The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer

TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer.

October 18, 2017

·

2 min read

Deals

Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

Optinose announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $16.00 per share.

October 18, 2017

·

3 min read

Biotech Beach

Prometheus Laboratories Release: New Test Monitors Therapeutic Ustekinumab Levels In IBD Patients

Prometheus Laboratories Inc. announces a new therapeutic drug monitoring test for use in adult inflammatory bowel disease (IBD) patients treated with Stelara (ustekinumab).

October 18, 2017

·

2 min read

Business

Albumedix Establishes Scientific Advisory Board

Albumedix has announced the formation of a Scientific Advisory Board (SAB) to provide governance, oversight and advice to Albumedix’s R&D organization as it builds and develops its pipeline of proprietary and differentiated drugs.

October 18, 2017

·

4 min read

Business

Pernix Therapeutics Announces Planned Departure of Chief Financial Officer

Graham Miao, Ph.D., President and Chief CFO, will leave the Company at the end of the year in order to pursue other opportunities.

October 18, 2017

·

3 min read

ANTABIO Raises 7.3M Euros Series A Financing To Develop Novel Treatments Against Drug-Resistant Gram-Negative Infections

Antabio SAS announced today the completion of a 7.3M Euros series A financing with subscriptions from investment funds iXO Private Equity, IRDI SORIDEC Gestion, Galia Gestion and from the company’s historical investors including former President of OM Pharma Christophe Ricard.

October 18, 2017

·

2 min read

Policy

Onxeo Reports First Instance Decision from the Commercial Court of Paris in the Lawsuit against SpeBio/SpePharm

The Court ordered Onxeo to pay SpeBio for costs incurred before termination the sum of 8.6 million euros with capitalized interest at the legal rate as of June 30, 2014.

October 18, 2017

·

5 min read